| Cep4lic vs Jin | 27–46 | 36.99% |
| Cep4lic vs Steve | 30–28 | 51.72% |
| Cep4lic vs King | 25–32 | 43.86% |
| Cep4lic vs Law | 15–40 | 27.27% |
| Cep4lic vs Reina | 19–33 | 36.54% |
| Cep4lic vs Dragunov | 14–31 | 31.11% |
| Cep4lic vs Heihachi | 17–25 | 40.48% |
| Cep4lic vs Kazuya | 12–23 | 34.29% |
| Cep4lic vs Hwoarang | 8–26 | 23.53% |
| Cep4lic vs Jun | 17–12 | 58.62% |
| Cep4lic vs Lidia | 15–13 | 53.57% |
| Cep4lic vs Lars | 8–19 | 29.63% |
| Cep4lic vs Victor | 14–12 | 53.85% |
| Cep4lic vs Bryan | 6–16 | 27.27% |
| Cep4lic vs Lili | 10–9 | 52.63% |
| Cep4lic vs Yoshimitsu | 8–9 | 47.06% |
| Cep4lic vs Paul | 7–9 | 43.75% |
| Cep4lic vs Nina | 6–10 | 37.50% |
| Cep4lic vs Shaheen | 4–11 | 26.67% |
| Cep4lic vs Eddy | 5–9 | 35.71% |
| Cep4lic vs Azucena | 4–9 | 30.77% |
| Cep4lic vs Devil Jin | 4–8 | 33.33% |
| Cep4lic vs Leo | 4–7 | 36.36% |
| Cep4lic vs Lee | 4–7 | 36.36% |
| Cep4lic vs Asuka | 6–4 | 60.00% |
| Cep4lic vs Alisa | 4–6 | 40.00% |
| Cep4lic vs Claudio | 4–6 | 40.00% |
| Cep4lic vs Clive | 3–7 | 30.00% |
| Cep4lic vs Feng | 1–8 | 11.11% |
| Cep4lic vs Kuma | 2–7 | 22.22% |
| Cep4lic vs Xiaoyu | 4–4 | 50.00% |
| Cep4lic vs Jack-8 | 2–6 | 25.00% |
| Cep4lic vs Raven | 2–6 | 25.00% |
| Cep4lic vs Leroy | 0–4 | 0.00% |
| Cep4lic vs Fahkumram | 1–3 | 25.00% |
| Cep4lic vs Zafina | 2–0 | 100.00% |
| Cep4lic vs Anna | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.